With pipelines diminishing and generics becoming more aggressive, pharmaceutical companies must maximize their brands' value and time on the market. A Guidebook to Pharma Brand Optimization analyzes the inner-workings of lifecycle management strategy, development and implementation processes.
Nov. 19POPLARVILLE Dr. James M. Riser said on Wednesday that about 500 school students here were vaccinated on Monday and Tuesday by health care officials, and that an additional round of vaccinations is planned for Dec. 14 to give students here another chance to get the swine flu shot. "We had hoped for at least 1,000, but it was still very s
A new company called the Emirates Biotech Pharmaceutical Factory LLC has been come up in the capital, which will set up new facilities to produce pharmaceuticals and raw materials based on biotechnology process. The products to be produced include crystal insulin for diabetes, anti-cancers, vaccines, haemophilia A and growth factors.
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is this week celebrating its 10th anniversary of providing central laboratory services throughout Europe.
3M Skin & Wound Care Division announced that the American Medical Association has created a new Category I Current Procedural Terminology (CPT) code that will describe the application of 3M Coban 2 Layer Compression System; CPT code 29581 - "Application of multi-layer venous wound compression system, below the knee."
Dublin - Research and Markets has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry" report to their offering. A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use.
11/20/09 ZoomMed Inc., creator of the ZRx Prescriber, the e-Pic communication network and the ZRx Pharma communication network announced during its shareholders meeting held today 10:00 am, the signing new contracts with pharmaceutical companies and the official launch of its e-Pic to pharmacies network. $1,482,500 in pharmaceutical contracts du
Antares Pharma, Inc. announced that it will release its third quarter 2009 financial results after the market closes on Monday, November 9, 2009, and host a conference call shortly thereafter at 4:30 PM to discuss the results. Interested parties may participate in the conference call by dialing 1-800-762-8908, or 480-629-9774, 5-10 minutes prior
LEXINGTON, Mass.-Biotechnology company Antigenics Inc. said Friday it will not seek approval for a potential kidney cancer treatment after a European advisory committee recommended against approving the drug candidate. The Committee for Medicinal Products for Human Use of The European Medicines Agency gave a negative opinion on the kidney cancer tr
Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world's top 20 pharmaceutical companies, can announce details of an Astellas Changing Tomorrow Charity Award for the International Foundation for Dermatology. The Astellas Changing Tomorrow Charity Awards complement the company's existing ongoing Corpo
AstraZeneca and the Philadelphia Department of Public Health announced today at a press conference at Philadelphia Health Care Center #6 that AstraZeneca will provide free medicines to the city's Health Centers to help uninsured Philadelphians access both the medical care and medications they need.
20 November 2009 - US biopharmaceutical company AVI BioPharma Inc said yesterday that data for its exon skipping therapy for Duchenne muscular dystrophy were reported at the TREAT-NMD / NIH International Conference that took place 17-19 November in Brussels, Belgium. At the conference, data from the company's clinical and preclinical programmes wer
EDITORS: The following are among the best commentaries, columns and editorials that moved this week on the McClatchy-Tribune News Service and are still suitable for use this weekend. For questions or retransmissions, please contact Op-Ed Editor E. Ray Walker, 202-383-6084, rwalker@mctinfoservices.com; or the News Desk, 202-383-6080.
BD today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, announced that it has closed a private placement of approximately $3.6 million worth of securities with certain accredited investors on Monday, November 2, 2009.
SRU Biosystems announced that Caliper Life Sciences will use SRU Biosystems' label-free BIND technology to offer new functional assays as part of its Discovery Alliances and Services. The label-free BIND technology, developed by SRU Biosystems, provides researchers with a new ultra-high throughput screening and profiling system for cell-based
Biopharmaceutical company Cell Therapeutics Inc said on Friday that it has won its appeal case to pursue a USD22.8m claim against The Lash Group, its former third-party reimbursement consultant for TRISENOX.
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial.
20 November 2009 - US pharmaceutical company Merck & Co Inc said today that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of ELONVA as a treatment in controlled ovarian stimulation in combination with a GnRH antagonist for the development of multiple follicles in women participating in an as
Nov. 19County commissioner Wayne Willingham addressed West Point's town council Monday evening regarding the county's proposed Smith Lake water project. "This is a feasible proposal," Willingham said. The county's plan includes upgrading the treatment facilities at Lake Catoma and constructing a new treatment facility that would pump water from S
Complete Genomics, a third-generation human genome sequencing company, announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today reported that it had received a Warning Letter from the Food and Drug Administration alleging that its Deconsal CT chewable tablets and Deconsal DM chewa
Las Vegas CRWENews.com is pleased to announce a stock highlight on IBM, Advanced Cell Technology, Inc. IBM announced today November 19, 2009 offers 10 new software products to help lower application management costs by optimizing the System z mainframe for more workloads, such as data analytics, collaborative application development, application ma
CVS Caremark announced it has extended its contract to provide retail pharmacy benefit services and all clinical services for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program. CVS Caremark has administered FEP's retail pharmacy benefit management program since 1993.
